Search details
1.
Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.
BMC Cancer
; 22(1): 759, 2022 Jul 12.
Article
in English
| MEDLINE | ID: mdl-35820813
2.
The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group "CNAPS/CTC for early detection of cancer".
Clin Chem Lab Med
; 60(6): 821-829, 2022 05 25.
Article
in English
| MEDLINE | ID: mdl-35218176
3.
Ensuring high standards for the delivery of NIPT world-wide: Development of an international external quality assessment scheme.
Prenat Diagn
; 39(5): 379-387, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30767256
4.
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.
BMC Cancer
; 18(1): 804, 2018 Aug 09.
Article
in English
| MEDLINE | ID: mdl-30092778
5.
Recommended practice for laboratory reporting of non-invasive prenatal testing of trisomies 13, 18 and 21: a consensus opinion.
Prenat Diagn
; 37(7): 699-704, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28497584
6.
External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme.
Virchows Arch
; 482(2): 347-355, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36355212
7.
Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey.
Virchows Arch
; 2023 May 19.
Article
in English
| MEDLINE | ID: mdl-37202567
8.
Expert opinion on NSCLC small specimen biomarker testing - Part 1: Tissue collection and management.
Virchows Arch
; 481(3): 335-350, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35857102
9.
Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.
Virchows Arch
; 481(3): 351-366, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35857103
10.
Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path).
Virchows Arch
; 479(6): 1067-1072, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-33856555
11.
Evaluation of current genetic testing reports in German-speaking countries with regard to secondary use and future electronic implementation.
Eur J Hum Genet
; 28(5): 558-566, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32055015
12.
External Quality Assessment Schemes for Biomarker Testing in Oncology: Comparison of Performance between Formalin-Fixed, Paraffin-Embedded-Tissue and Cell-Free Tumor DNA in Plasma.
J Mol Diagn
; 22(6): 736-747, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32205291
13.
One byte at a time: evidencing the quality of clinical service next-generation sequencing for germline and somatic variants.
Eur J Hum Genet
; 28(2): 202-212, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31570784
14.
Current practices for the genetic diagnosis of autoinflammatory diseases: results of a European Molecular Genetics Quality Network Survey.
Eur J Hum Genet
; 27(10): 1502-1508, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31186541
15.
IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
Virchows Arch
; 474(6): 681-689, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-31028539
16.
Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme.
Virchows Arch
; 482(2): 357, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36482100
17.
Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland.
Genet Test
; 10(3): 147-56, 2006.
Article
in English
| MEDLINE | ID: mdl-17020464
18.
Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.
Arch Pathol Lab Med
; 139(4): 522-9, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25061833
19.
Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers' survey.
Virchows Arch
; 471(6): 809-813, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28840321
20.
Benchmark for evaluating the quality of DNA sequencing: proposal from an international external quality assessment scheme.
Clin Chem
; 52(4): 728-36, 2006 Apr.
Article
in English
| MEDLINE | ID: mdl-16455867
Results
1 -
20
de 20
1
Next >
>>